First Manhattan’s Diebold Nixdorf Incorporated DBD Stock Holding History

First Manhattan’s Portfolio DBD Stock Details DBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,000	Closed	-$1.2K	–	1580
2023 Q1	$1.2K	Buy	+1,000	New	+$2.23K	﹤0.01%	1415
2018 Q4	–	Sell	-137,500	Closed	-$618K	–	1460
2018 Q3	$618K	Buy	+137,500	New	+$1M	﹤0.01%	549

Other funds holding DBD

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

BFIM

Beese Fulmer Investment Management Canton, Ohio $1.56B AUM 26.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

First Manhattan's DBD Position: Q2 2023 in Review

First Manhattan sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 1,000 shares — an estimated $1.2K sold.

First Manhattan first reported a position in DBD in Q3 2018 and held it in 2 quarters. The position peaked at $618K in Q3 2018. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

First Manhattan reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
First Manhattan sold 1,000 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $1.2K.
First Manhattan first reported a position in Diebold Nixdorf Incorporated in Q3 2018 and held it in 2 quarters.
First Manhattan's Diebold Nixdorf Incorporated position peaked at $618K in Q3 2018.
7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on First Manhattan's 13F filing for Q2 2023, filed 14 Aug 2023.